Immune response, inflammation, and the clinical spectrum of COVID-19

Cited by (740)

Items 101–200 of 740

1. Cutting Edge: Distinct B Cell Repertoires Characterize Patients with Mild and Severe COVID-19
   Kenneth B. Hoehn, Palaniappan Ramanathan, Avraham Unterman, Tomokazu S. Sumida, Hiromitsu Asashima, David A. Hafler, Naftali Kaminski, Charles S. Dela Cruz, Stuart C. Sealfon, Alexander A. Bukreyev et al. · 2021 · The Journal of Immunology
2. Irisin, Exercise, and COVID-19
   Hugo Rodrigues Alves, Guilherme Schittine Bezerra Lomba, Cassiano Felippe Gonçalves-de-Albuquerque, Patrícia Burth · 2022 · Frontiers in Endocrinology
3. Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults
   Maria Raffaella Petrara, Francesco Bonfante, Paola Costenaro, Anna Cantarutti, Francesco Carmona, Elena Ruffoni, Costanza Di Chiara, Marisa Zanchetta, Luisa Barzon, Daniele Donà et al. · 2021 · Frontiers in Immunology
4. COVID-19 and obesity: fighting two pandemics with intermittent fasting
   Kafi N. Ealey, J Cole Phillips, Hoon‐Ki Sung · 2021 · Trends in Endocrinology and Metabolism
5. SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters
   Peter Halfmann, Noriko Nakajima, Yuko Sato, Kenta Takahashi, Molly A. Accola, Shiho Chiba, Shufang Fan, Gabriele Neumann, William M. Rehrauer, Tadaki Suzuki et al. · 2021 · The Journal of Infectious Diseases
6. Characteristics of COVID-19 Breakthrough Infections among Vaccinated Individuals and Associated Risk Factors: A Systematic Review
   Shilpa Gopinath, Angela Ishak, Naveen Dhawan, Sujan Poudel, Prakriti Singh Shrestha, Prabhjeet Singh, Emily Xie, Peggy Tahir, Sima Marzaban, Jack Michel et al. · 2022 · Tropical Medicine and Infectious Disease
7. Absolute Lymphocytes, Ferritin, C-Reactive Protein, and Lactate Dehydrogenase Predict Early Invasive Ventilation in Patients With COVID-19
   Salvador Payán‐Pernía, Lucía Gómez Pérez, Angel Francisco Remacha, Jordi Sierra Gil, Silvana Novelli · 2020 · Laboratory Medicine
8. Repurposing of the herbal formulations: molecular docking and molecular dynamics simulation studies to validate the efficacy of phytocompounds against SARS-CoV-2 proteins
   Chinmayi Joshi, Armi M Chaudhari, Chaitanya G. Joshi, Madhvi N. Joshi, Snehal B. Bagatharia · 2021 · Journal of Biomolecular Structure and Dynamics
9. Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19
   Pradeep Singh Cheema, Deeptashree Nandi, Alo Nag · 2021 · Open Biology
10. Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer
    Arielle Elkrief, Julie Tsu-Yu Wu, Chinmay Jani, Kyle T. Enriquez, Michael J. Glover, Mansi R. Shah, Hira Ghazal Shaikh, Alicia C. Beeghly-Fadiel, Benjamin C. French, Sachin R. Jhawar et al. · 2021 · Cancer Discovery
11. COVID-19: General Strategies for Herbal Therapies
    Samaneh Soleymani, Ayeh Naghizadeh, Mehrdad Karimi, Azadeh Zarei, Raefeh Mardi, Gholamreza Kordafshari, Niusha Esmaealzadeh, Arman Zargaran · 2022 · Journal of Evidence-Based Integrative Medicine
12. The potential impact of Covid-19 on CNS and psychiatric sequels
    Ali Dehghani, Elham Zokaei, Seyyed Mohammad Kahani, Elaheh Alavinejad, Mohammad Dehghani, Gholam Hossein Meftahi, Mohammad Reza Afarinesh · 2022 · Asian Journal of Psychiatry
13. Risk factors for severe COVID-19 in middle-aged patients without comorbidities: a multicentre retrospective study
    Peng Wang, Jing Sha, Mei Meng, Cuiyan Wang, Qingchun Yao, Zhongfa Zhang, Wenqing Sun, Xingguang Wang, Guoqiang Qie, Xue Bai et al. · 2020 · Journal of Translational Medicine
14. uhrf1 and dnmt1 Loss Induces an Immune Response in Zebrafish Livers Due to Viral Mimicry by Transposable Elements
    Elena Magnani, Filippo Macchi, Bhavani P. Madakashira, Chi Zhang, Fatima AlAydaroos, Kirsten C. Sadler · 2021 · Frontiers in Immunology
15. Axonal Guillain‐Barre syndrome associated with SARS‐CoV‐2 infection in a child
    Nihal Akçay, Mehmet Emin Menentoğlu, Gonca Bektaş, Esra Şevketoğlu · 2021 · Journal of Medical Virology
16. Mesenchymal Stem Cells for the Compassionate Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID 19
    M. Iglesias, P. Butrón, Iván Torre-Villalvazo, Erik A. Torre-Anaya, J. Sierra-Madero, J. J. Rodríguez-Andoney, A. Tovar-Palacio, A. Zentella-Dehesa, G. Dominguez-Cherit, T. Rodríguez-Reyna et al. · 2021 · Aging and Disease
17. Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19
    Jintao Zhang, Chunyuan Zhao, Wei Zhao · 2021 · Frontiers in Immunology
18. COVID-19, Pre-Eclampsia, and Complement System
    Chiara Agostinis, Alessandro Mangogna, Andrea Balduit, Azin Aghamajidi, Giuseppe Ricci, Uday Kishore, Roberta Bulla · 2021 · Frontiers in Immunology
19. Regulatory T Cells as Predictors of Clinical Course in Hospitalised COVID-19 Patients
    Sara Caldrer, Cristina Mazzi, Milena Bernardi, Marco Giuseppe Prato, Niccolò Ronzoni, Paola Rodari, Andrea Angheben, Chiara Piubelli, Natalia Tiberti · 2021 · Frontiers in Immunology
20. Waning of Anti-spike Antibodies in AZD1222 (ChAdOx1) Vaccinated Healthcare Providers: A Prospective Longitudinal Study
    Sanjeeb Kumar Mishra, Subrat Kumar Pradhan, Sanghamitra Pati, Sumanta Sahu, Rajiv K Nanda · 2021 · Cureus
21. Assessment of tryptophan and kynurenine as prognostic markers in patients with SARS-CoV-2
    Simon Michaelis, Sieglinde Zelzer, Wolfgang Johann Schnedl, Andreas Baranyi, Andreas Meinitzer, Dietmar Enko · 2021 · Clinica Chimica Acta
22. Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19
    Alish Palmos, Vincent Millischer, David Krishna Menon, Timothy R. Nicholson, Leonie S. Taams, Benedict Daniel Michael, Geraint J. Sunderland, Michael John Griffiths, Christopher Hübel, Gerome D. Breen · 2022 · PLoS Genetics
23. Characterization of long COVID-19 manifestations and its associated factors: A prospective cohort study from Iran
    Mona Sadat Larijani, Fatemeh Ashrafian, Fahimeh Bagheri Amiri, Mohammad Banifazl, Anahita Bavand, Afsaneh Karami, Fatemeh Asgari Shokooh, Amitis Ramezani · 2022 · Microbial Pathogenesis
24. Silencing of lncRNA MIAT alleviates LPS-induced pneumonia via regulating miR-147a/NKAP/NF-κB axis
    Min Liu, Weixin Li, Fuxing Song, Ling Zhang, Xianjun Sun · 2020 · Aging
25. A sensitive indicator for the severity of COVID-19: thiol
    Özcan Erel, Salim Neşeli̇oğlu, Merve Ergin Tunçay, Esra Fırat Oğuz, Funda Karakoyunlu Eren, Meryem Sena Akkuş, Rahmet Güner, İhsan Ateş · 2020 · TURKISH JOURNAL OF MEDICAL SCIENCES
26. Rapid GMP-Compliant Expansion of SARS-CoV-2–Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19
    Rachel S. Cooper, Alasdair R. Fraser, Linda M. Smith, Paul Burgoyne, Stuart N. Imlach, LISA M. JARVIS, David M. Turner, Sharon Zahra, Marc L. Turner, John D. Campbell · 2021 · Frontiers in Immunology
27. Coronavirus disease 2019 and neurodegenerative disease: what will the future bring?
    Lindsay S. McAlpine, Arman Fesharaki‐Zadeh, Serena Spudich · 2020 · Current Opinion in Psychiatry
28. Expression of Endogenous Angiotensin-Converting Enzyme 2 in Human Induced Pluripotent Stem Cell-Derived Retinal Organoids
    Henkie Isahwan Ahmad Mulyadi Lai, Shih‐Jie Chou, Yueh Chien, Ping‐Hsing Tsai, Chian‐Shiu Chien, Chih‐Chien Hsu, Ying-Chun Jheng, Mong‐Lien Wang, Shih‐Hwa Chiou, Yu-Bai Chou et al. · 2021 · International Journal of Molecular Sciences
29. Therapeutic Potential of Exploiting Autophagy Cascade Against Coronavirus Infection
    Subhajit Maity, A. Saha · 2021 · Frontiers in Microbiology
30. Innate Immune Response in SARS-CoV-2 Infection
    Giovanna Schiuma, Silvia Beltrami, Daria Bortolotti, Sabrina Rizzo, Roberta Rizzo · 2022 · Microorganisms
31. Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients
    Mohammad A. Al-Mterin, Alhasan Alsalman, Eyad Elkord · 2022 · Frontiers in Immunology
32. A review on the immune responses against novel emerging coronavirus (SARS-CoV-2)
    Ramin Lotfi, Rasoul Nasiri Kalmarzi, Seyed Askar Roghani · 2021 · Immunologic Research
33. Biomedical Waste and Solid Waste Management in the Time of COVID-19: A Comprehensive Review of the National and International Scenario and Guidelines
    Malini Rajinder Capoor, Annapurna Parida · 2021 · Journal of Laboratory Physicians
34. Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection
    Aifen Lin, Wei‐Hua Yan · 2021 · Frontiers in Immunology
35. Early Response of CD8+ T Cells in COVID-19 Patients
    Deni Ramljak, Martina Vukoja, Marina Ćurlin, Katarina Vukojević, Maja Barbarić, Una Glamočlija, Bejana Purisevic, Olivera Perić, Violeta Šoljić · 2021 · Journal of Personalized Medicine
36. Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity
    Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Kuldeep Dhama, Sang‐Soo Lee · 2022 · World Journal of Gastroenterology
37. Peripheral Blood Immune Profiling of Convalescent Plasma Donors Reveals Alterations in Specific Immune Subpopulations Even at 2 Months Post SARS-CoV-2 Infection
    Nikolaos Orologas‐Stavrou, Marianna Politou, Pantelis Rousakis, Ioannis V. Kostopoulos, Ioannis Ntanasis‐Stathopoulos, Edison Jahaj, Eleni Tsiligkeridou, Maria Gavriatopoulou, Efstathios Kastritis, Αnastasia Kotanidou et al. · 2020 · Viruses
38. Acute Kidney Disease and Mortality in Acute Kidney Injury Patients with COVID-19
    Filipe Cordeiro Marques, Joana Gameiro, João Pedro Oliveira, José Agapito Fonseca, Inês Duarte, João Bernardo, Carolina Branco, Cláudia Costa, Carolina Carreiro, Sandra Bráz et al. · 2021 · Journal of Clinical Medicine
39. Phage therapy in the Covid-19 era: Advantages over antibiotics
    Atif Khan, Toleti Subba Rao, Hiren Joshi · 2022 · Current Research in Microbial Sciences
40. Palmitoylethanolamide (PEA) Inhibits SARS-CoV-2 Entry by Interacting with S Protein and ACE-2 Receptor
    Rossella Fonnesu, V. B. S. C. Thunuguntla, Ganesh Kumar Veeramachaneni, Jayakumar Singh Bondili, Veronica La Rocca, Carolina Filipponi, Pietro Giorgio Spezia, Maria Sidoti, Erika Plicanti, Paola Quaranta et al. · 2022 · Viruses
41. Characterisation of the blood RNA host response underpinning severity in COVID-19 patients
    Heather Jackson, Irene Rivero Calle, Claire M. Broderick, Dominic Habgood-Coote, Giselle D’Souza, Samuel Nichols, Ortensia Vito, José Gómez Rial, Carmen Rivero-Velasco, Nuria Rodríguez‐Núñez et al. · 2022 · Scientific Reports
42. Risk of hospitalization and sequelae in patients with COVID‐19 treated with 3‐day early remdesivir vs. controls in the vaccine and Omicron era: A real‐life cohort study
    Maria Mazzitelli, Mattia Trunfio, Lolita Sasset, Vincenzo Scaglione, Anna Maria Ferrari, Daniele Mengato, Samuele Gardin, Nicola Bonadiman, Lucrezia Calandrino, Elena Agostini et al. · 2023 · Journal of Medical Virology
43. Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran
    ‪Mostafa Salehi-Vaziri, Tahmineh Jalali, Behrokh Farahmand, Fatemeh Fotouhi, Mohammad Banifazl, Mohammad Hassan Pouriayevali, Mona Sadat Larijani, Neda Afzali, Amitis Ramezani · 2021 · European Journal of Clinical Microbiology & Infectious Diseases
44. Acute and Chronic Effects of COVID-19 on the Cardiovascular System
    Víctor Arévalos, Luis Ortega‐Paz, Juan José Rodríguez-Arias, Margarita Calvo-López, Leticia Camino Castrillo Golvano, Anthony Salazar-Rodríguez, Marta Sabaté-Tormos, Francesco Spione, Manel Sabaté, Salvatore Brugaletta · 2021 · Journal of Cardiovascular Development and Disease
45. Anti-VEGF agents: As appealing targets in the setting of COVID-19 treatment in critically ill patients
    Adeleh Sahebnasagh, Seyed Mohammad Nabavi, Hamid Reza Khayat Kashani, Safieh Aghaabdollahian, Solomon Habtemariam, Aysa Rezabakhsh · 2021 · International Immunopharmacology
46. Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh
    Afroza Akter, Tasnuva Ahmed, Imam Tauheed, Marjahan Akhtar, Sadia Isfat Ara Rahman, Fatema Khaton, Faisal Ahmmed, Jannatul Ferdous, Mokibul Hassan Afrad, Zannat Kawser et al. · 2022 · PLoS neglected tropical diseases
47. Role of Urinary Kidney Stress Biomarkers for Early Recognition of Subclinical Acute Kidney Injury in Critically Ill COVID-19 Patients
    Gustavo Alejandro Casas-Aparicio, Claudia Alvarado‐de la Barrera, David Escamilla-Illescas, Isabel León-Rodríguez, Perla M. Del Río Estrada, Natalia Calderón-Dávila, Mauricio González-Navarro, Rossana Olmedo-Ocampo, Manuel de Jesús Castillejos-López, Liliana Figueroa-Hernández et al. · 2022 · Biomolecules
48. Transmission roles of symptomatic and asymptomatic COVID-19 cases: a modelling study
    Jianbin Tan, Yang Ge, Leonardo Martínez, Jimin Sun, Changwei Li, Adrianna Lynn Westbrook, Enfu Chen, Jinren Pan, Yang Li, Wei Cheng et al. · 2022 · Epidemiology and Infection
49. Transcutaneous Auricular Vagus Nerve Stimulation Improves Inflammation but Does Not Interfere with Cardiac Modulation and Clinical Symptoms of Individuals with COVID-19: A Randomized Clinical Trial
    Fernanda Ishida Corrêa, Paulo Henrique Leite Souza, Laura Uehara, Raphael Mendes Ritti‐Dias, Gustavo Oliveira da Silva, Wellington Segheto, Kevin Pacheco‐Barrios, Felipe Fregni, João Carlos Ferrari Corrêa · 2022 · Life
50. Coronavirus infection: An immunologists' perspective
    Juan Bautista De Sanctis, Alexis Hipólito García, Dolores Moreno, Marián Hajdúch · 2021 · Scandinavian Journal of Immunology
51. Impact of metabolic and cardiovascular disease on COVID-19 mortality: A systematic review and meta-analysis
    Shubham Sahni, Gaurav Gupta, Radhika Sarda, Shivam Pandey, Ravindra Mohan Pandey, Sanjeev Sinha · 2021 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
52. VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells
    Jairo Ramos Temerozo, Carolina Q. Sacramento, Natalia Fintelman Rodrigues, Camila R. R. Pão, Caroline Souza de Freitas, Suelen da Silva Gomes Dias, André Costa Ferreira, Mayara Mattos, Vinícius Cardoso Soares, Lívia Teixeira et al. · 2022 · Journal of Leukocyte Biology
53. Targeting Nrf2 by bioactive peptides alleviate inflammation: expanding the role of gut microbiota and metabolites
    Zhongxing Chu, Lingfeng Zhu, Yaping Zhou, Feiyan Yang, Zuomin Hu, Yi Luo, Wen Li, Feijun Luo · 2024 · Critical Reviews in Food Science and Nutrition
54. Inflammatory-Related Clinical and Metabolic Outcomes in COVID-19 Patients
    María Martínez‐Urbistondo, Alberto Mora Vargas, Esther Expósito-Palomo, Raquel Castejón, María Jesús Citores, Silvia Rosado, Carmen de Mendoza, Isolina Baños, Ana Fernández‐Cruz, Lidia Daimiel et al. · 2020 · Mediators of Inflammation
55. Edible and Herbal Plants for the Prevention and Management of COVID-19
    Sha Li, Chien‐shan Cheng, Cheng Zhang, Guoyi Tang, Hor‐Yue Tan, Haiyong Chen, Ning Wang, Agnes Yuen Kwan Lai, Yibin Feng · 2021 · Frontiers in Pharmacology
56. Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2
    Pankaj Kumar Ahluwalia, Kumar Vaibhav, Meenakshi Ahluwalia, Ashis Kumar Mondal, Nikhil Sahajpal, Amyn M. Rojiani, Ravindra B Kolhe · 2021 · Frontiers in Immunology
57. In-Silico analysis reveals lower transcription efficiency of C241T variant of SARS-CoV-2 with host replication factors MADP1 and hnRNP-1
    Armi M Chaudhari, Minal Chaudhari, Sapna Mahera, Zuber Saiyed, Neelam Mustakali Nathani, Shantanu P. Shukla, Dhaval Patel, Chirag Patel, Madhvi N. Joshi, Chaitanya G. Joshi · 2021 · Informatics in Medicine Unlocked
58. Vitamin D and COVID-19: where are we now?
    Victoria Contreras-Bolívar, Beatriz García-Fontana, Cristina García‐Fontana, Manuel Muñoz‐Torres · 2021 · Postgraduate Medicine
59. DNA-launched RNA replicon vaccines induce potent anti-SARS-CoV-2 immune responses in mice
    I. Szurgot, L. Hanke, D. Sheward, L. P. Vidakovics, B. Murrell, G. Mcinerney, P. Liljeström · 2021 · Scientific Reports
60. Experience of olokizumab use in COVID-19 patients
    Антонов Владимир Николаевич, Galina L. Ignatova, O. V. Pribytkova, Снежана Спиридоновна Слепцова, Е.А. Strebkova, Худякова Елена Алексеевна, A. I. Simakov, Рабец Станислав Юрьевич, Елена Петровна Тихонова, Курмаева Джамиля Юсуповна et al. · 2020 · Terapevticheskii arkhiv
61. Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits
    A. Banerjee, Upasana Ganguly, S. Saha, S. Chakrabarti, R. Saini, R. Rawal, L. Saso, Sasanka Chakrabarti · 2021 · Expert Review of Anti-Infective Therapy
62. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades
    L. Ponoop Prasad Patro, Chakkarai Sathyaseelan, Patil Pranita Uttamrao, Thenmalarchelvi Rathinavelan · 2021 · Infection Genetics and Evolution
63. Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients
    Tommaso Schioppo, Lorenza Maria Argolini, Savino Sciascia, Francesca Pregnolato, Francesco Tamborini, Paolo Miraglia, Dario Roccatello, Renato Alberto Sinico, Roberto Felice Caporali, Gabriella Luisa Moroni et al. · 2021 · Lara D. Veeken
64. What Happens to the Immune System after Vaccination or Recovery from COVID-19?
    Bruna Tiaki Tiyo, Gabriela J. H. Schmitz, Marina Mazzilli Ortega, Laís T. da Silva, Alexandre de Almeida, Telma Miyuki Oshiro, Alberto José da Silva Duarte · 2021 · Life
65. Interplay between Inflammaging, Frailty and Nutrition in Covid-19: Preventive and Adjuvant Treatment Perspectives
    A. Padilha de Lima, Marcelo Macedo Rogero, Tânia Araújo Viel, Miguel Garay-Malpartida, Iván Aprahamian, Sandra María Lima Ribeiro · 2021 · The journal of nutrition health & aging
66. Epidemiology, clinical presentation and management of COVID‐19 associated mucormycosis: A single centre experience from Pune, Western India
    Ameet N. Dravid, Reema Kashiva, Zafer A. Khan, Balasaheb D Bande, Danish Memon, Aparna Kodre, Prashant Potdar, Milind Mane, Asir Tamboli, Vishal Pawar et al. · 2022 · Mycoses
67. La proporción de proteína C reactiva a linfocitoE es un marcador confiable en pacientes con infección por COVID-19; el estudio CLEAR COVID
    Burçin Meryem Atak Tel, Gizem Kahveci, Gülali Aktaş, Muhammed Emin Demirkol, Özge Kurtkulağı, Satılmış Bilgin, Tuba Taslamacıoğlu Duman · 2022 · Cirugía y Cirujanos
68. Implication of Aging Related Chronic Neuroinflammation on COVID-19 Pandemic
    Paola Bossù, Elisa Toppi, Valentina Sterbini, Gianfranco Spalletta · 2020 · Journal of Personalized Medicine
69. Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C)
    Frans A. Kuypers, Christina A. Rostad, Evan J. Anderson, Ann Chahroudi, Preeti Jaggi, Jens Wrammert, Grace E. Mantus, Rajit K. Basu, Frank L. Harris, Bradley S. Hanberry et al. · 2021 · Experimental Biology and Medicine
70. A possible pathogenic correlation between neutrophil elastase (NE) enzyme and inflammation in the pathogenesis of coronavirus disease 2019 (COVID-19)
    Sajad Karampoor, Khashayar Hesamizadeh, Faezeh Maleki, Mohammad Farahmand, Hamid Zahednasab, Rasoul Mirzaei, Hélène Banoun, Farhad Zamani, Marzieh Hajibaba, Alireza Tabibzadeh et al. · 2021 · International Immunopharmacology
71. Genetic variants in the NF-κB signaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients
    Daniel G. Camblor, Daniel Miranda, Guillermo M. Albaiceta, Laura Amado‐Rodríguez, Elías Cuesta‐Llavona, Daniel Vázquez‐Coto, Julia Gómez de Oña, Claudia García-Lago, Juan Gómez, Eliécer Coto · 2022 · Human Immunology
72. Kinetics of SARS-CoV-2 IgM and IgG Antibodies 3 Months after COVID-19 Onset in Moroccan Patients
    Najlaa Assaid, Soukaina Arich, Hicham Charoute, Khadija Akarid, Mohamed Anouar Sadat, Abderrahmane Maaroufi, Sayeh Ezzikouri, M’hammed Sarih · 2022 · American Journal of Tropical Medicine and Hygiene
73. Global impact of environmental temperature and BCG vaccination coverage on the transmissibility and fatality rate of COVID-19
    Amit Kumar, Shubham Misra, Vivek Verma, Ramesh Kumar Vishwakarma, Vineet Kumar Kamal, Manabesh Nath, Kiran Prakash, Ashish Datt Upadhyay, Jitendra Kumar Sahu · 2020 · PLoS ONE
74. Assessment of the Herd Immunity to SARS-CoV-2 among the Population of the Leningrad Region during the COVID-19 Epidemic
    A. Yu. Popova, Elena B. Ezhlova, Albina A. Melnikova, O. A. Historik, O. S. Mosevich, Liudmila V. Lyalina, В. С. Смирнов, M. A. Cherny, N. S. Balabysheva, I. S. Loginova et al. · 2020 · Problems of Particularly Dangerous Infections
75. From Anti-SARS-CoV-2 Immune Response to the Cytokine Storm via Molecular Mimicry
    Darja Kanduc · 2021 · Antibodies
76. COVID-19 Transcriptomic Atlas: A Comprehensive Analysis of COVID-19 Related Transcriptomics Datasets
    Fatma Alqutami, Abiola Catherine Senok, Mahmood Yaseen Hachim · 2021 · Frontiers in Genetics
77. Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives
    Weiqi Yao, Lei Shi, Yun Zhang, Haibo Dong, Yu Zhang · 2022 · Stem Cell Research & Therapy
78. Steroid harms if given early in COVID-19 viraemia
    Kanupriya Arora, Prasan Kumar Panda · 2021 · BMJ Case Reports
79. Anti-Inflammatory Properties of Drugs Used to Control COVID-19 and their Effects on the Renin-Angiotensin System and Angiotensin-Converting Enzyme-2
    Hamed Gilzad Kohan, Fakhreddin Jamali · 2020 · Journal of Pharmacy & Pharmaceutical Sciences
80. Understanding the pathogenesis of infectious diseases by single-cell RNA sequencing
    Wanqiu Huang, Danni Wang, Yufeng Yao · 2021 · Microbial Cell
81. IgG Antibodies Generation and Side Effects Caused by Ad5-nCoV Vaccine (CanSino Biologics) and BNT162b2 Vaccine (Pfizer/BioNTech) among Mexican Population
    Oscar Guzmán-Martínez, Kathia Guardado, Elsa Ladrón de Guevara, Saturnino Mezcua Navarro, Crescencio Hernández, Roberto Zenteno‐Cuevas, Hilda Montero · 2021 · Vaccines
82. Predicting prognosis in COVID-19 patients using machine learning and readily available clinical data
    T. Campbell, Melissa P. Wilson, Heinrich Röder, Samantha MaWhinney, Robert W. Georgantas, Laura K. Maguire, Joanna Roder, Kristine Mace Erlandson · 2021 · International Journal of Medical Informatics
83. Sex and organ-specific risk of major adverse renal or cardiac events in solid organ transplant recipients with COVID-19
    Amanda Jean Vinson, Ran Dai, Gaurav Agarwal, Alfred Jerrod Anzalone, Stephen B. Lee, Evan French, Amy L. Olex, Vithal Madhira, Roslyn Bernstein Mannon · 2021 · American Journal of Transplantation
84. Epidemiological and Immunological Features of Obesity and SARS-CoV-2
    Eric James Nilles, Sameed M. Siddiqui, Stephanie Fischinger, Yannic C. Bartsch, Michael de St. Aubin, Guohai Zhou, Matthew J. Gluck, Samuel Berger, Justin Rhee, Eric Petersen et al. · 2021 · Viruses
85. The Importance of Nutraceuticals in COVID-19: What’s the Role of Resveratrol?
    Elisa Domi, Malvina Hoxha, Entela Kolovani, Domenico Tricarico, Bruno Zappacosta · 2022 · Molecules
86. Impact of prior vaccination on clinical outcomes of patients with COVID-19
    Woo Jung Seo, Jiyeon Kang, Hyung Koo Kang, So Hee Park, Hyeon‐Kyoung Koo, Hye Kyeong Park, Sung-Soon Lee, Je Eun Song, Yee Gyung Kwak, Jieun Kang · 2022 · Emerging Microbes & Infections
87. Does post-COVID reactive arthritis exist? Experience of a tertiary care centre with a review of the literature
    Atanu Pal, Rashmi Roongta, Sumantro Mondal, Debanjali Sinha, Pradyot Sinhamahapatra, Alakendu Ghosh, Arghya Chattopadhyay · 2022 · Reumatología Clínica
88. Definitions matter: Heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis
    Philippe Jean Guerin, Alistair R. D. McLean, Sumayyah Rashan, AbdulAzeez Lawal, James A Watson, Nathalie Strub Wourgaft, Nicholas John White · 2022 · PLOS Global Public Health
89. Computational simulations to dissect the cell immune response dynamics for severe and critical cases of SARS-CoV-2 infection
    Rodolfo Blanco‐Rodríguez, Xin Du, Esteban Abelardo Hernandez-Vargas · 2021 · Computer Methods and Programs in Biomedicine
90. Broad auto-reactive IgM responses are common in critically ill patients, including those with COVID-19
    Andrew Kam Ho Wong, Isaac B. Woodhouse, Frank Schneider, Deanna A. Kulpa, Guido Silvestri, Cheryl L. Maier · 2021 · Cell Reports Medicine
91. A Multidisciplinary Approach to Coronavirus Disease (COVID-19)
    Aliye Gediz Ertürk, Arzu Şahin, Ebru Batı Ay, Emel Pelit, Emine Bağdatlı, Irem Kulu, Melek Gül, Seda Mesci̇, Serpil Eryılmaz, Sirin Oba Ilter et al. · 2021 · Molecules
92. Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19?
    Kátia Nunes da Silva, André Luiz Nunes Gobatto, Zaquer Suzana Munhoz Costa‐Ferro, Bruno Raphael Ribeiro Cavalcante, Alex Cleber Improta Caria, Luciana Souza de Aragão França, Carolina Kymie Vasques Nonaka, Fernanda de Macêdo Lima, Miquéias Lopes‐Pacheco, Patrícia R. M. Rocco et al. · 2021 · Stem Cell Research & Therapy
93. Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence
    Riccardo Sarzani, Francesco Spannella, Federico Giulietti, Chiara Di Pentima, Piero Giordano, Andrea Giacometti · 2021 · Internal and Emergency Medicine
94. Is There a Role for SARS-CoV-2/COVID-19 on the Female Reproductive System?
    Silvia D’Ippolito, Francesca Turchiano, Amerigo Vitagliano, Gennaro Scutiero, Antonio Lanzone, Giovanni Scambia, Pantaleo Greco · 2022 · Frontiers in Physiology
95. Living in a Hostile World: Inflammation, New Drug Development, and Coronavirus
    Geoffrey Phillip Dobson, Erik Biroš, Hayley L. Letson, Jodie L. Morris · 2021 · Frontiers in Immunology
96. Intracranial Hemorrhage in Patients with Coronavirus Disease 2019 (COVID-19): A Case Series
    Rawad Abbas, Kareem El Naamani, Ahmad Sweid, Joseph W. Schaefer, Kimon Bekelis, Nader Antoine Sourour, Mahmoud Elhorany, Aditya Swarup Pandey, Stavropoula I. Tjoumakaris, Michael Reid Gooch et al. · 2021 · World Neurosurgery
97. Murine-β-coronavirus-induced neuropathogenesis sheds light on CNS pathobiology of SARS-CoV2
    Debanjana Chakravarty, Jayasri Das Sarma · 2021 · Journal of NeuroVirology
98. Accurate point-of-care serology tests for COVID-19
    Charles Frank Schuler IV, Carmen Gherasim, Kelly M. O’Shea, David M. Manthei, Jesse Chen, Don Giacherio, Jonathan P. Troost, James L. Baldwin, James R. Baker · 2021 · PLoS ONE
99. Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis
    Miguel Ángel Casillas Santana, Juan Antonio Arreguín-Cano, Alejandro Dib Kanán, Farid Alonso Dipp Velázquez, Paulina del Carmen Sosa Munguía, Gabriel Alejandro Martínez-Castañón, Brenda Castillo, Carolina Sámano Valencia, Marco Felipe Salas Orozco · 2021 · Medicina
100. Assessment and Management of Long COVID
     Rafael A. Rivas-Vazquez, Gustavo J. Fonseca D’El Rey, Alan Quintana, Ana A. Rivas-Vazquez · 2022 · Journal of Health Service Psychology